Revvity expects full-year earnings in the range of $4.90 to $5 per share, with revenue in the range of $2.8 billion to $2.85 billion. This story was generated by Automated Insights ( http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RVTY at https://www.zacks.com/ap/RVTY

Thermo Fisher Scientific on Thursday beat Wall Street estimates for fourth-quarter profit and revenue, helped by improved demand for its products and services used in developing therapies. Contract drug manufacturers witnessed reduced spending from biotech clients in the past two years,

For the current quarter ending in March, Dynatrace expects its per-share earnings to range from 29 cents to 31 cents. The company said it expects revenue in the range of $432 million to $437 million for the fiscal fourth quarter.

Dynatrace (DT) announced that its corporate headquarters is relocating to downtown Boston, Massachusetts. The company will move from its

(RTTNews) - Dynatrace, Inc. (DT), Thursday announced the decision to relocate its Corporate headquarters to downtown Boston, Massachusetts from its current Waltham, Massachusetts location in Spring of 2025. The move aims to enhance workplace experience by providing easier access to work with customers, partners, and other stakeholders.

Shortly after 10:30 a.m., the Cambridge Fire Department announced it was assisting the Waltham Fire Department in a mutual aid response for a third-alarm fire at the Fernald School property at 200 Trapelo Road.

WALTHAM, Mass. (AP) — WALTHAM, Mass. (AP) — Thermo Fisher Scientific Inc. (TMO) on Thursday reported fourth-quarter profit of $1.83 billion. On a per-share basis, the Waltham, Massachusetts-based company said it had net income of $4.78. Earnings, adjusted for one-time gains and costs, were $6.10 per share.

Thermo Fisher Scientific on Thursday forecast annual profit above Wall Street estimates, banking on improved demand for its products and services used in developing therapies, sending its shares up 6.

The firm reported that its full-year 2024 revenues were up slightly as a rise in the diagnostics business was mostly offset by a decline in life sciences business.

Wednesday’s fatal crash of a civilian plane and military helicopter at Reagan National Airport may reflect rising stresses on air-safety systems.

Thermo Fisher Scientific (TMO) stock gains as the company beats Q4 2024 expectations and sets 2025 earnings outlook in line with consensus. Read more here.

Wall Street banks are getting ready to sell up to $3 billion of debt holdings in X, the social-media platform controlled by Elon Musk, two sources with knowledge of the matter said Friday.